Michael G. Backlund

2.6k total citations
19 papers, 1.1k citations indexed

About

Michael G. Backlund is a scholar working on Pharmacology, Cancer Research and Molecular Biology. According to data from OpenAlex, Michael G. Backlund has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Michael G. Backlund's work include Inflammatory mediators and NSAID effects (10 papers), Cancer, Lipids, and Metabolism (6 papers) and Estrogen and related hormone effects (5 papers). Michael G. Backlund is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Cancer, Lipids, and Metabolism (6 papers) and Estrogen and related hormone effects (5 papers). Michael G. Backlund collaborates with scholars based in United States, Canada and Italy. Michael G. Backlund's co-authors include Raymond N. DuBois, Jason R. Mann, Vijaykumar Holla, Sudhansu K. Dey, F. Gregory Buchanan, Dingzhi Wang, Ginger L. Milne, Erik S. Musiek, Sharada Katkuri and Hsin-Hsiung Tai and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Clinical Microbiology.

In The Last Decade

Michael G. Backlund

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael G. Backlund United States 14 551 342 219 195 184 19 1.1k
Haruki Kato Japan 11 793 1.4× 289 0.8× 274 1.3× 248 1.3× 491 2.7× 38 1.4k
Stephanie J. Muga United States 17 229 0.4× 605 1.8× 157 0.7× 177 0.9× 145 0.8× 26 1.4k
Masoumeh Tavakoli‐Yaraki Iran 23 208 0.4× 554 1.6× 289 1.3× 205 1.1× 195 1.1× 60 1.2k
I F Stamford United Kingdom 19 804 1.5× 239 0.7× 151 0.7× 234 1.2× 288 1.6× 43 1.3k
Leonardo A. Moraes United Kingdom 21 163 0.3× 709 2.1× 133 0.6× 121 0.6× 64 0.3× 30 1.5k
Lihua Tan China 18 338 0.6× 571 1.7× 67 0.3× 100 0.5× 110 0.6× 32 1.3k
Ju‐Hee Kang South Korea 23 217 0.4× 800 2.3× 188 0.9× 260 1.3× 108 0.6× 67 1.5k
Chang‐Kwon Lee South Korea 23 305 0.6× 601 1.8× 62 0.3× 131 0.7× 59 0.3× 47 1.1k
Isao Eto United States 21 112 0.2× 701 2.0× 147 0.7× 233 1.2× 218 1.2× 51 1.3k

Countries citing papers authored by Michael G. Backlund

Since Specialization
Citations

This map shows the geographic impact of Michael G. Backlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Backlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Backlund more than expected).

Fields of papers citing papers by Michael G. Backlund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Backlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Backlund. The network helps show where Michael G. Backlund may publish in the future.

Co-authorship network of co-authors of Michael G. Backlund

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Backlund. A scholar is included among the top collaborators of Michael G. Backlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Backlund. Michael G. Backlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Anderson, Cole, François Lebreton, Brendan T. Jones, et al.. (2024). Molecular Surveillance of Multidrug-Resistant Bacteria among Refugees from Afghanistan in 2 US Military Hospitals during Operation Allies Refuge, 2021. Emerging infectious diseases. 30(14). 47–52. 3 indexed citations
2.
Backlund, Michael G., et al.. (2023). Multi-Disciplinary Design of an LH2 Powered Regional Jet. AIAA SCITECH 2023 Forum.
3.
Mills, Emma G., Melissa J. Martin, Ana Ong, et al.. (2022). A one-year genomic investigation of Escherichia coli epidemiology and nosocomial spread at a large US healthcare network. Genome Medicine. 14(1). 147–147. 23 indexed citations
4.
Robinson, Sara, et al.. (2022). Infective endocarditis due to Haemophilus sputorum. Access Microbiology. 4(12). acmi000410–acmi000410. 1 indexed citations
5.
Dyke, T A Van, Victor Weigman, Karen Rasmussen, et al.. (2019). Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. UNC Libraries. 1 indexed citations
6.
Cardile, Anthony P., et al.. (2016). Deployment of the 1st Area Medical Laboratory in a Split-Based Configuration During the Largest Ebola Outbreak in History. Military Medicine. 181(11). e1675–e1684. 3 indexed citations
7.
McGann, Patrick, Michael Milillo, Robert Clifford, et al.. (2013). Detection of New Delhi Metallo-β-Lactamase (Encoded by bla NDM-1 ) in Acinetobacter schindleri during Routine Surveillance. Journal of Clinical Microbiology. 51(6). 1942–1944. 14 indexed citations
8.
Miller, Melissa B., et al.. (2011). Performance of Xpert MTB/RIF RUO Assay and IS 6110 Real-Time PCR for Mycobacterium tuberculosis Detection in Clinical Samples. Journal of Clinical Microbiology. 49(10). 3458–3462. 57 indexed citations
9.
Horn, Leora, Michael G. Backlund, & David H. Johnson. (2009). Targeting the eicosanoid pathway in non-small-cell lung cancer. Expert Opinion on Therapeutic Targets. 13(6). 675–688. 14 indexed citations
10.
Wang, Dingzhi, Haibin Wang, Ning Wei, et al.. (2008). Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth. Cancer Research. 68(15). 6468–6476. 138 indexed citations
11.
Backlund, Michael G., Jason R. Mann, Vijaykumar Holla, et al.. (2008). Repression of 15-Hydroxyprostaglandin Dehydrogenase Involves Histone Deacetylase 2 and Snail in Colorectal Cancer. Cancer Research. 68(22). 9331–9337. 47 indexed citations
12.
Holla, Vijaykumar, et al.. (2008). Regulation of Prostaglandin Transporters in Colorectal Neoplasia. Cancer Prevention Research. 1(2). 93–99. 70 indexed citations
13.
Jania, Leigh A., Subhashini Chandrasekharan, Michael G. Backlund, et al.. (2008). Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins & Other Lipid Mediators. 88(3-4). 73–81. 68 indexed citations
14.
Backlund, Michael G., Jason R. Mann, Dingzhi Wang, & Raymond N. DuBois. (2006). Ras Up‐Regulation of Cyclooxygenase‐2. Methods in enzymology on CD-ROM/Methods in enzymology. 407. 401–410. 15 indexed citations
15.
Mann, Jason R., Michael G. Backlund, F. Gregory Buchanan, et al.. (2006). Repression of Prostaglandin Dehydrogenase by Epidermal Growth Factor and Snail Increases Prostaglandin E2 and Promotes Cancer Progression. Cancer Research. 66(13). 6649–6656. 85 indexed citations
16.
Musiek, Erik S., Ling Gao, Ginger L. Milne, et al.. (2005). Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages. Journal of Biological Chemistry. 280(42). 35562–35570. 80 indexed citations
17.
Backlund, Michael G., Jason R. Mann, & Raymond N. DuBois. (2005). Mechanisms for the Prevention of Gastrointestinal Cancer: The Role of Prostaglandin E<sub>2</sub>. Oncology. 69(Suppl. 1). 28–32. 87 indexed citations
18.
Mann, Jason R., Michael G. Backlund, & Raymond N. DuBois. (2005). Mechanisms of Disease: inflammatory mediators and cancer prevention. Nature Clinical Practice Oncology. 2(4). 202–210. 124 indexed citations
19.
Backlund, Michael G., Jason R. Mann, Vijaykumar Holla, et al.. (2004). 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer. Journal of Biological Chemistry. 280(5). 3217–3223. 240 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026